Jamesf Young News Today

Deeply embattled biotechnology specialist Novavax (NASDAQ:NVAX) popped dramatically higher on Monday, closing up 11.25% against the Friday session.

Novavax CEO and President Stanley C. Erck, who led the company during its drive to produce a COVID-19 vaccine, is stepping down, the Gaithersburg-based firm announced Monday. He will be succeeded by John C. Jacobs, effective Jan. 23, the company said in a news release. Erck will serve as an adviser to the company for ...

A seasonably cool evening welcomed Soho denizens assembled at the little wedge park they call their own,  Father Fagan Park. 

Mary Lou Young, of Lancaster, beloved wife, mother, and grandmother, died peacefully on Monday, November 7, 2022 at Homestead Village. She was 94 years old. Born in Manheim in 1928,

Novavax, Inc. (NASDAQ:NVAX – Get Rating) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 12,100,000 shares, a decrease of 15.3% from the May 15th total of 14,290,000 shares. Based on an average daily volume of 5,510,000 shares, the short-interest ratio is currently […]

Novavax, Inc. (NASDAQ:NVAX – Get Rating) has received a consensus recommendation of “Hold” from the nine ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have given a buy recommendation to the company. The […]

Wall Street brokerages expect Novavax, Inc. (NASDAQ:NVAX – Get Rating) to post $1.04 billion in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Novavax’s earnings. The highest sales estimate is $1.13 billion and the lowest is $953.48 million. Novavax posted sales of $298.02 million during the same quarter last […]

Novavax, Inc. (NASDAQ:NVAX – Get Rating) has earned a consensus recommendation of “Hold” from the ten research firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating on the company. The […]

Equities analysts expect Novavax, Inc. (NASDAQ:NVAX – Get Rating) to report sales of $878.11 million for the current quarter, Zacks reports. Four analysts have made estimates for Novavax’s earnings, with the highest sales estimate coming in at $1.04 billion and the lowest estimate coming in at $760.00 million. Novavax posted sales of $447.23 million in […]

State of Michigan Retirement System acquired a new position in shares of Novavax, Inc. (NASDAQ:NVAX – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,400 shares of the biopharmaceutical company’s stock, valued at approximately $200,000. Other hedge funds and other institutional […]